Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

AbbVie and Anima collaborate for mRNA biology modulators

January 11, 2023 Research and Development

AbbVie and Amina Biotech have announced their collaboration for the discovery and development of mRNA biology modulators focusing on three …
News

FDA grants approval to third-generation VERO Biotech GENOSYL delivery system

January 11, 2023 Research and Development

The FDA has approved US-based medical equipment supplier VERO Biotech’s new-generation tankless inhaled nitric oxide (iNO) delivery system. This new …
News

Day One Biopharmaceuticals to file NDA for paediatric brain cancer treatment before second half of 2023

January 10, 2023 Research and Development

Day One Biopharmaceuticals is set to ask the FDA for approval for tovorafenib before the summer of 2023. Tovorafenib is …
News

FDA approves Eisai-Biogen’s lecanemab for Alzheimer’s disease

January 9, 2023 Research and Development

The FDA has approved Eisai and Biogen’s experimental antibody treatment lecanemab (also known as Leqembi) for the treatment of mild …
News

Island Pharmaceuticals to begin phase 2 trial for dengue prevention and treatment drug

January 5, 2023 Research and Development

It is possible that Island Pharmaceuticals could begin its phase 2a PEACH clinical trial as soon as January 2023. The …
News

Belharra Therapeutics and Genentech join forces for small molecule medicine development

January 5, 2023 Research and Development

US-based biotech companies Belharra Therapeutics and Genentech have announced a multi-year partnership to lead the discovery and development of small …
News

Biogen and Alcyone Therapeutics enter partnership to develop ThecaFlex DRx system for ASO therapies

January 5, 2023 Research and Development

US-based Biogen and Alcyone Therapeutics have entered into a license and collaboration agreement to develop Alcyone’s ThecaFlex DRx™ System.   …
News

Rare cancer drug for young patients approved

January 3, 2023 Research and Development

A new treatment option for adult and paediatric patients with a rare soft tissue cancer has been approved. The FDA …
News

Abiomed receives FDA approval for heart pump clinical trial

December 22, 2022 Research and Development

Abiomed, a leading provider of medical technology focusing on the circulatory system and oxygenation, has announced that the FDA has …
News

Idorsia submits new drug application to FDA for aprocitentan to treat difficult-to-control hypertension

December 20, 2022 Research and Development

Idorsia has announced that it has submitted a new drug application (NDA) to the FDA in hopes of gaining approval …
News

AlzeCure has abstract accepted on possible disease-modifying effects of ACD856 against Alzheimer’s

December 20, 2022 Research and Development

AlzeCure, a pharma company who focuses on its portfolio of small molecule candidate drugs for central nervous system (CNS) diseases, …
News

New study shares effectiveness of asthma drug compared to standard of care

December 19, 2022 Research and Development

The University of Plymouth has co-authored a new study, published in The Lancet, which shows how an asthma drug, commercially …
News

Targeted imaging agent for lung cancer surgery approved by FDA

December 19, 2022 Research and Development

The FDA has approved Cytalux (pafolacianine) to be used in lung cancer surgery: the targeted imaging agent binds to cancerous …
News

CDC provides $12.5m grant to study real-world effectiveness of vaccines

December 16, 2022 Research and Development

The Center for Disease Control and Prevention (CDC) has given researchers at Washington University School of Medicine in St Louis, …
News

New blood test appears to detect hidden cancer

December 16, 2022 Research and Development

Biotech company Guardant Health has announced that its blood test-based cancer screening technique appears to be effective: the liquid biopsy …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026